Verastem Inc VSTM

US Biotechnology

$8.59 ▼ -1.26% ($-0.11)

🔥 High Short Interest

Open $8.55

Prev Close $8.70

Day Range $8.43 – $8.80

52W Range $3.43 – $10.82

Market Cap $1.18B

Beta 0.65

EPS (TTM) $-2.46

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2011-11-08
Shares Out.	121,420,000
Website	verastem.com/ ↗
Phone	13026587581
Employees	102
Revenue	$40.1M
Gross Profit	$36.0M
Net Income	-$34.7M
Free Cash Flow	-$162.2M
Total Assets	$206.5M
Total Liabilities	$156.5M
Equity	$50.0M

About Verastem Inc

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem Inc is a publicly traded company under the ticker symbol VSTM on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.